Evidence map›Paper›PMID 39390445›Full record

ArticleBMC cancer2024

Investigation of the distribution of inguinal lymph nodes and delineation of the inguinal clinical target volume using

Jia-Li Han, Yan-Ge Qi, Jia-Ling Liu, Xia Yan, Wan-Chun Zhang, Ling Yuan, Xin-Zhong Hao, Jian-Bo Song, Si-Jin Li

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jia-Li HanDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Yan-Ge QiShanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, 030032, China.
Jia-Ling LiuShanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, 030032, China.
Xia YanShanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, 030032, China.
Wan-Chun ZhangShanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, 030032, China.
Ling YuanDepartment of PET/CT, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, 030013, China.
Xin-Zhong HaoDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Jian-Bo SongShanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, 030032, China. jianbo2611@126.com.
Si-Jin LiDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China. lisjnm123@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRadiotherapy is a crucial treatment modality for pelvic cancers, but uncertainties persist in defining the clinical target volume (CTV) for the inguinal lymphatic drainage region. Suboptimal CTV delineation may compromise treatment efficacy and result in subpar disease control. This study aimed to investigate and map the distribution of lymph node metastases (LNM) in the groin area to facilitate an improved and detailed CTV definition using

methodsInguinal LNM in patients with biopsy-proven pelvic malignancies were identified using

resultsIn this study, 500 positive LNM were identified by

conclusionsUsing

Indexed as

Fluorodeoxyglucose F18Lymphatic MetastasisLymph NodesPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overFemaleGroinHumansInguinal CanalMaleMiddle AgedPelvic NeoplasmsRadiopharmaceuticalsYoung AdultFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTClinical target volumeInguinal lymph nodes metastasesIntensity-modulated radiotherapyPelvic and perineal cancer

Identifiers

PMID39390445
PMCPMC11465914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.